Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The European Spallation Source (ESS) is a multi-disciplinary research facility based on the world's most powerful pulsed neutron source. Located in Lund, Sweden, it is a collaborative project involving 13 European nations organized as a European Research Infrastructure Consortium (ERIC). ESS provides advanced neutron scattering techniques that enable scientists to study the structure and dynamics of materials at the atomic and molecular levels. In the life sciences, the facility supports research into protein structures, drug delivery systems, and biological membranes, offering insights that are often unattainable with X-ray methods. The facility is currently under construction and commissioning, aiming to become a cornerstone of European research innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Spallation Source.